Skip to main content
Fig. 2 | Genome Medicine

Fig. 2

From: Pan-cancer identification of clinically relevant genomic subtypes using outcome-weighted integrative clustering

Fig. 2

Outcome-weighted integrative clustering of low-grade glioma (LGG) and kidney papillary cell carcinoma using survClust. a survClust identifies an IDH-mutant CDKN2A-loss subtype similar to IDH-wt tumors in terms of the aggressive clinical behavior. Top: Kaplan-Meier curves of the integrated survClust subtypes of LGG. Middle: Panelmap summarizing major association of mutational and clinical features of the integrated LGG subtypes. Bottom: Copy number profile for each of the integrated subtypes. b survClust identifies prognostic kidney papillary renal cell carcinoma (KIRP) subtypes

Back to article page